Per Basse, MD, PhD, DM.Sci.

Assistant Member (Clinical Research)
DoM - Translational Research
Roswell Park Comprehensive Cancer Center
Areas of Expertise: 
Immunology, Immunotherapy & Immuno-histology
Image Analysis
Animal Models, Cancer
Natural killer (NK) cells
Lymphocyte Traffic
Drug delivery (lymphocyte based
Microscopy, Confocal, Fluorescence, Live cell
Special Interests: 
Cancer Immunotherapy
Cytotoxic T and NK cells
Lymphocyte Traffic
Drug delivery
Live Cell Microscopy


I received my M.D. from the University of Aarhus, Denmark, in 1984. Following a residency at the Department of Hematology, Aarhus County Hospital, I was lucky enough to get funding to set up a PhD project to study the trafficking of metastasizing tumor cells as well as activated NK cells at the Department of Immunology at the Institute of Medical Microbiology, University of Aarhus, Denmark. 
In 1988 I received a fellowship from the Fogarty International Center, NIH, to study in the US for 1-2 years. I also received an invitation from Ronald B. Herberman, M.D., to join the newly established Pittsburgh Cancer Institute, as a visiting fellow. It was during this period my interest in NK cells changed from serious to passionate as I, against my own predictions, showed that under the right conditions, NK cells localize in high numbers and with impressive selectivity at tumor sites. 
I returned to Denmark two years later to finish my Ph.D. in Immunology (“Tissue distribution of NK cells and their role in clearance and metastasis of tumor cells”, University of Aarhus, 1992. Mentors: Dr. Marianne Hokland, M.D., Ph.D., and the late Dr. Iver Heron, M.D., Ph.D.), but at the end of my “two year home-rule” in 1992, I was recruited back to the University of Pittsburgh Cancer Institute (UPCI) to study cancer immunotherapy based on NK cells, cytotoxic T cells and dendritic cells. 
In the summer of 2017, I accepted an exciting offer from Roswell Park Cancer Institute to join the newly formed Division of Translational Research, DoM, under the leadership of my friend and former colleague from Pittsburgh, Dr. Pawel Kalinski. While I, in this new position, continue to study traffic and anti-tumor function of immune effector cells, a major and very important and very satisfying difference is that I am now given the possibility to apply myself and my insights from years of animal-based studies directly to translational and clinical cancer research. 


Education and Training: 
PhD, 1992 University of Aarhus, Denmark. Cancer Immunology/immunotherapy
MD, 1984 University of Aarhus, Denmark
DM.Sci., 1996 University of Aarhus, Denmark. Immunology/Cancer Immunology
1984, Aarhus University Hospital, Denmark. Hematology
Fogarty International Center Fellowship (NIH). Anti-cancer effect of NK cells. 1988-1990
Honors and Awards: 
Collaborative IDEA Award (Department of Defense, USA) 2011
Concept Award (Department of Defense, USA) 2008
The 2003 Excellence in Education Awards (Nominee – Small Group Facilitators)
The 2003 Excellence in Education Awards (Nominee – Lecturers)
PA Breast Cancer Coalition Research Grant Award (PA Dept. Health). 2002
Concept Award (Department of Defense, USA) 2000
IDEA Award (Department of Defense, USA) 1997
First Independent Research Support and Transition Award (NIH)